Apeiron Capital's complete divestment from SharpLink Gaming coincides with the firm's dramatic portfolio liquidation and SharpLink's own radical transformation from a sports betting affiliate to a major corporate holder of Ethereum.
While quantum computing startups capture headlines, IBM's decades-long investment and recent Nighthawk processor breakthrough are drawing serious capital from institutional investors, signaling enduring dominance in the enterprise quantum race.
While Intel's struggles capture public attention and government subsidies, a less-heralded semiconductor titan, Broadcom, is forging a formidable path in AI through its deep partnership with Alphabet and a business model built for the long haul.
Tesla's strategic pivot from electric vehicles to AI and robotics, coupled with declining automotive revenue, has created a stark divide among analysts. Bullish forecasts see shares hitting $500, while bears warn of a drop to $350, leaving investors to weigh Elon Musk's high-stakes vision against core business challenges.
As global demand for copper surges—driven by AI data centers, electrification, and green energy—a severe supply crunch looms. Mining magnate Robert Friedland warns of a looming 'train wreck,' putting companies like Southern Copper and Freeport-McMoRan in the spotlight for investors.
Amidst a resilient market backdrop, we spotlight three U.S. stocks trading significantly below their estimated intrinsic value, offering potential for investors willing to navigate current volatility.
Alliance Resource Partners (ARLP) posted a significant jump in fourth-quarter profit, driven by cost controls and investment gains, even as coal revenue softened. The partnership issued 2026 guidance pointing to robust contract coverage and a growing oil & gas royalty segment, while navigating challenges at a key Appalachian mine.
The Long Island-based lender has posted its first quarterly profit since a surprise loss in 2023, marking a pivotal turnaround driven by a strategic shift away from troubled CRE loans and toward commercial and industrial lending.
Despite lagging the broader market over the past year, fertilizer giant Mosaic is showing signs of a rebound in 2026. Analysts maintain a cautiously optimistic 'Moderate Buy' stance, eyeing a potential recovery in crop nutrient demand.
Tenet Healthcare has regained complete ownership of its revenue cycle management subsidiary Conifer, buying out CommonSpirit Health's minority stake in a deal valued at nearly $2.7 billion. The move signals Tenet's renewed commitment to the business and plans for significant AI investment.
AIGH Capital Management has liquidated its entire position in semiconductor firm MaxLinear, a move that coincides with the chipmaker's recent strong quarterly earnings report, raising questions about the fund's strategy.
While Las Vegas Sands shares have struggled to keep pace with the broader market, a majority of Wall Street analysts maintain a constructive outlook, betting on a recovery in Macau and the company's long-term integrated resort model.
While Aptiv shares have cooled off in 2026 after a strong run, Wall Street remains overwhelmingly bullish, with price targets suggesting potential gains of over 30% from current levels.
As United Parcel Service executes a strategic overhaul focused on profitability over volume, its financials reveal a nascent but promising trend, leading some investors to see a potential rebound on the horizon despite recent stock declines.
Despite a volatile post-earnings reaction, Invesco Ltd. maintains robust analyst support with upgraded ratings and bullish price targets, as the asset manager's strategic moves and inflows fuel optimism.
A volatile January has underscored a stark shift for investors: political shocks emanating from Washington now pose a greater threat to portfolios than traditional economic or earnings concerns, reshaping risk calculus across global markets.
Southwest Airlines' stock just logged its biggest daily gain since 1978, fueled by a decisive break from its past. As bag fees, assigned seating, and new revenue streams take hold, the carrier's bold transformation is winning over Wall Street and setting the stage for a projected profit surge.
While Legend Biotech's CAR-T therapy Carvykti missed Q4 sales estimates, prompting mixed analyst reactions, some firms emphasize its curative potential and view the stock's recent decline as a strategic entry point for investors.
Investment firm William Blair has initiated coverage on Rambus Inc. with an 'Outperform' rating, highlighting the chip designer's dominant market share in interface circuits and its strategic positioning to capitalize on surging demand from AI data centers and server DRAM upgrades.
Barclays reaffirms its Overweight rating on Meta Platforms, raising its price target to $800, citing robust Q4 recovery and surging ad revenue. The upgrade follows CEO Mark Zuckerberg's announcement of a massive $115B-$135B AI infrastructure investment plan for 2026.
